BIIB
|Biogen Inc
NASDAQ
Current Price
USD 131.84
Change
USD -1.03 (-0.78%)
P/E Ratio
12.41
Dividend Yield
Market Cap
18.40B
Volume
161,533
Open
USD 132.10
Previous Close
USD 132.87
52-Week High
USD 238.00
52-Week Low
USD 110.04
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar refer...
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
AMGEN Inc.
AMGN • NASDAQ
Gilead Sciences, Inc.
GILD • NASDAQ
Abbvie Inc
ABBV • NEW YORK STOCK EXCHANGE INC.
Pfizer Inc.
PFE • NEW YORK STOCK EXCHANGE INC.
Johnson & Johnson
JNJ • NEW YORK STOCK EXCHANGE INC.
Bio-Rad Laboratories Inc.
BIO • NEW YORK STOCK EXCHANGE INC.
Illumina Inc
ILMN • NASDAQ
Qiagen NV
QGEN • NEW YORK STOCK EXCHANGE INC.